Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women

[1]  L. Vatten,et al.  Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients , 2013, Breast Cancer Research and Treatment.

[2]  W. Willett,et al.  Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. , 2013, American journal of epidemiology.

[3]  M. Fernö,et al.  The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer , 2013, SpringerPlus.

[4]  S. Hofvind,et al.  Breast cancer incidence trends in Norway—explained by hormone therapy or mammographic screening? , 2012, International journal of cancer.

[5]  J. Palmer,et al.  Parity and Lactation in Relation to Estrogen Receptor Negative Breast Cancer in African American Women , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[6]  R. Prentice,et al.  Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. , 2011, Journal of the National Cancer Institute.

[7]  K. Kerlikowske,et al.  Reproductive history and risk of three breast cancer subtypes defined by three biomarkers , 2011, Cancer Causes & Control.

[8]  Victoria L. Cafourek,et al.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. , 2011, Journal of the National Cancer Institute.

[9]  Marvin Zelen,et al.  Effect of screening mammography on breast-cancer mortality in Norway. , 2010, The New England journal of medicine.

[10]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[11]  Christine B Ambrosone,et al.  Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors , 2009, Breast Cancer Research.

[12]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[13]  P. Porter,et al.  Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer , 2009, Cancer.

[14]  K. Jacobsen,et al.  A systematic review of the association between breastfeeding and breast cancer. , 2008, Journal of women's health.

[15]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[16]  Samuel Leung,et al.  Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.

[17]  S. Hofvind,et al.  Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program , 2008, Acta oncologica.

[18]  M. García-Closas,et al.  Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[19]  M. Pike,et al.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies , 2006, Breast Cancer Research.

[20]  B. Strom,et al.  Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology , 2005, British Journal of Cancer.

[21]  M. García-Closas,et al.  Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[23]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[24]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[26]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[27]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.

[28]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[29]  Ivar Heuch,et al.  A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. , 1987, American journal of epidemiology.

[30]  Ivar Heuch,et al.  A prospective study of reproductive factors and breast cancer. I. Parity. , 1987, American journal of epidemiology.

[31]  P. Porter,et al.  Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of age , 2012, Breast Cancer Research and Treatment.

[32]  Sunil R. Lakhani,et al.  WHO classification of tumours of the breast , 2012 .

[33]  G. Colditz,et al.  Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer , 2011, Breast Cancer Research and Treatment.

[34]  R. Goldbohm,et al.  Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease , 2002 .

[35]  R. Millikan,et al.  Risk of breast cancer according to the status of HER-2/neu oncogene amplification. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.